Department of Community Health Sciences, State University of New York, Downstate Medical Center School of Public Health, Brooklyn, New York.
School of Social Work, University of Alabama, Tuscaloosa, Alabama.
Am J Prev Med. 2018 Jun;54(6):756-764. doi: 10.1016/j.amepre.2018.02.012. Epub 2018 Apr 12.
This study assessed longitudinal relationships between patient healthcare empowerment, engagement in care, and viral control in the Women's Interagency HIV Study, a prospective cohort study of U.S. women living with HIV.
From April 2014 to March 2016, four consecutive 6-month visits were analyzed among 973 women to assess the impact of Time 1 healthcare empowerment variables (Tolerance for Uncertainty and the state of Informed Collaboration Committed Engagement) on Time 2 reports of ≥95% HIV medication adherence and not missing an HIV primary care appointment since last visit; and on HIV RNA viral control across Times 3 and 4, controlling for illicit drug use, heavy drinking, depression symptoms, age, and income. Data were analyzed in 2017.
Adherence of ≥95% was reported by 83% of women, 90% reported not missing an appointment since the last study visit, and 80% were categorized as having viral control. Logistic regression analyses revealed a significant association between the Informed Collaboration Committed Engagement subscale and viral control, controlling for model covariates (AOR=1.08, p=0.04), but not for the Tolerance for Uncertainty subscale and viral control (AOR=0.99, p=0.68). In separate mediation analyses, the indirect effect of Informed Collaboration Committed Engagement on viral control through adherence (β=0.04, SE=0.02, 95% CI=0.02, 0.08), and the indirect effect of Informed Collaboration Committed Engagement on viral control through retention (β=0.01, SE=0.008, 95% CI=0.001, 0.030) were significant. Mediation analyses with Tolerance for Uncertainty as the predictor did not yield significant indirect effects.
The Informed Collaboration Committed Engagement healthcare empowerment component is a promising pathway through which to promote engagement in care among women living with HIV.
本研究评估了患者医疗保健授权、参与护理和病毒控制之间的纵向关系,该研究是在美国妇女艾滋病毒研究中进行的一项前瞻性队列研究。
从 2014 年 4 月至 2016 年 3 月,对 973 名女性进行了连续四次 6 个月的访视,以评估时间 1 医疗保健授权变量(不确定性容忍度和知情协作承诺状态)对时间 2 报告的影响,报告的时间 2 为≥95%的 HIV 药物依从性和自上次就诊以来未错过 HIV 初级保健预约;以及在时间 3 和 4 时的 HIV RNA 病毒控制,控制非法药物使用、大量饮酒、抑郁症状、年龄和收入。数据于 2017 年进行分析。
83%的女性报告了≥95%的依从性,90%的女性报告自上次研究就诊以来未错过预约,80%的女性被归类为具有病毒控制。逻辑回归分析显示,在控制模型协变量后,知情协作承诺子量表与病毒控制显著相关(AOR=1.08,p=0.04),但不确定性容忍度子量表与病毒控制不相关(AOR=0.99,p=0.68)。在单独的中介分析中,通过依从性(β=0.04,SE=0.02,95%CI=0.02,0.08)和通过保留(β=0.01,SE=0.008,95%CI=0.001,0.030),知情协作承诺对病毒控制的间接效应在统计学上显著。以不确定性容忍度为预测因子的中介分析没有产生显著的间接效应。
知情协作承诺的医疗保健授权组成部分是促进 HIV 感染者参与护理的一个有前途的途径。